相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic phenotyping applied to pre-clinical and clinical studies of acetaminophen metabolism and hepatotoxicity
Muireann Coen
DRUG METABOLISM REVIEWS (2015)
Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical Implications
Chris Stockmann et al.
CLINICAL PHARMACOKINETICS (2014)
Dosing in Children: A Critical Review of the Pharmacokinetic Allometric Scaling and Modelling Approaches in Paediatric Drug Development and Clinical Settings
Iftekhar Mahmood
CLINICAL PHARMACOKINETICS (2014)
Neonatal clinical pharmacology
Karel Allegaert et al.
PEDIATRIC ANESTHESIA (2014)
Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6
Mara R. Livezey et al.
XENOBIOTICA (2014)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
PHASE II DRUG METABOLIZING ENZYMES
Petra Jancova et al.
BIOMEDICAL PAPERS-OLOMOUC (2010)
Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia
Wilna J. Moree et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Specific aspects of gastro-intestinal transit in children for drug delivery design
Alexandra Bowles et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Developmental Pharmacokinetics
Gail D. Anderson
SEMINARS IN PEDIATRIC NEUROLOGY (2010)
Essentials for starting a pediatric clinical study (1): Pharmacokinetics in children
Tsuyoshi Yokoi
JOURNAL OF TOXICOLOGICAL SCIENCES (2009)
Human UDP-glucuronosyltransferase UGT2A2: cDNA construction, expression, and functional characterization in comparison with UGT2A1 and UGT2A3
Nina Sneitz et al.
PHARMACOGENETICS AND GENOMICS (2009)
Inhibition and induction of human cytochrome P450 enzymes: current status
Olavi Pelkonen et al.
ARCHIVES OF TOXICOLOGY (2008)
Developmental changes in human liver CYP2D6 expression
Jeffrey C. Stevens et al.
DRUG METABOLISM AND DISPOSITION (2008)
The ontogeny of drug metabolism enzymes and implications for adverse drug events
Ronald N. Hines
PHARMACOLOGY & THERAPEUTICS (2008)
Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population
Helena Buzkova et al.
CELL BIOCHEMISTRY AND FUNCTION (2008)
Codeine and tramadol analgesic efficacy and respiratory effects are influenced by CYP2D6 genotype
U. M. Stamer et al.
ANAESTHESIA (2007)
Effect of diet on the development of drug metabolism by cytochrome P-450 enzymes in healthy infants
Michael J. Blake et al.
PEDIATRIC RESEARCH (2006)
Pharmacological research in pediatrics: From neonates to adolescents
NY Rakhmanina et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations
Imke H. Bartelink et al.
CLINICAL PHARMACOKINETICS (2006)
Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism
SK Krueger et al.
PHARMACOLOGY & THERAPEUTICS (2005)
UDP-glucuronosyltransferases and clinical drug-drug interactions
TKL Kiang et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Clarithromycin-nifedipine interaction as possible cause of vasodilatory shock
M Gerónimo-Pardo et al.
ANNALS OF PHARMACOTHERAPY (2005)
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity
M Ingelman-Sundberg
PHARMACOGENOMICS JOURNAL (2005)
Developmental expression of human hepatic CYP2C9 and CYP2C19
SB Koukouritaki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: Theory and clinical reality, part II
SC Armstrong et al.
PSYCHOSOMATICS (2003)
The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children
TN Johnson
TOXICOLOGY (2003)
Human hepatic CYP2E1 expression during development
EK Johnsrud et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Developmental pharmacology - Drug disposition, action, and therapy in infants and children
GL Kearns et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Pharmacokinetics in the newborn
J Alcorn et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Developmental expression of the major human hepatic CYP3A enzymes
JC Stevens et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Role of P-glycoprotein in pharmacokinetics - Clinical implications
JH Lin et al.
CLINICAL PHARMACOKINETICS (2003)
The ontogeny of human drug-metabolizing enzymes: Phase II conjugation enzymes and regulatory mechanisms
DG McCarver et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression
SB Koukouritaki et al.
PEDIATRIC RESEARCH (2002)
Effects of grapefruit juice on the pharmacokinetics of sildenafil
A Jetter et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
分享论文
